Search Results 51-60 of 26254 for chemoprevention
... chemopreventive agents. Improving cancer risk prediction through studies ... chemoprevention (delivered with efficacy while minimizing adverse events) ...
Related. Breast cancer · Breast cancer chemoprevention · What is breast cancer? An expert explains. News from Mayo Clinic. Assessing breast cancer risk March 15 ...
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer. Rochester, Minn. The purpose of this study is to learn whether it is better to receive ...
Mayo Clinic offers educational resources to patients with cancer, their families, and those in their support network.
The first chemoprevention phase 0 exploratory pharmacokinetic clinical trial (first-in-man) of the Akt inhibitor SR13668 to establish a formulation with the ...
The study will determine breast density (MMG) and correlate with qLI. The study will also determine the influence of chemoprevention therapies such as tamoxifen ...
See also. Atypical hyperplasia of the breast · Breast cancer · Breast Cancer · Breast cancer chemoprevention · Breast Cancer Education Tool · Common questions ...
Patients who received tamoxifen or raloxifene for purposes of chemoprevention (e.g., Breast Cancer Prevention Trial) or for other indications (including ...
... chemopreventive strategies for liver disease such as PSC, PBC, PLD, NAFLD, NASH, ASH, HCC, donors (non-diseased and diseased) for liver transplant or non ...
No concurrent tamoxifen or other SERMs; Prior tamoxifen or other selective estrogen receptor modulator (SERM) for chemoprevention (e.g., Breast Cancer ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.